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Objective: B1a lymphocytesdwhich constitutively produce most natural antibodies (NAb)darise
from an early wave of progenitors unique to fetal life. Vitamin A regulates early lymphopoiesis. In
animals, deﬁciency during this critical period compromises B1 cell populations. The aim of this
study was to investigate the effect of maternal supplementation with vitamin A or b-carotene from
preconception through lactation on NAb concentrations of offspring.
Methods: Participants (N ¼ 290) were born to participants of a cluster-randomized, placebo-
controlled trial of weekly maternal vitamin A or b-carotene supplementation (7000 mg retinol
equivalents) conducted in Sarlahi, Nepal (1994–1997) and assessed at ages 9 to 13 y (2006–2008).
Serum retinol was measured by reversed-phase high-performance liquid chromatography at mid-
pregnancy and 3 mo of age. Enzyme-linked immunosorbent assay (ELISA) was used to measure
children’s plasma NAb concentrations at 9 to 13 y.
Results: Unadjusted geometric mean concentrations were 20.08 U/mL (95% conﬁdence interval [CI],
17.82–22.64) in the vitamin A group compared with 17.64 U/mL (95% CI, 15.70–19.81) and 15.96 U/
mL (95% CI, 13.43–18.96) in the b-carotene and placebo groups (P ¼ 0.07), respectively. After
adjustment, maternal vitamin A supplementation was associated with a 0.39 SD increase in NAb
concentrations (P ¼ 0.02). The effect was mediated by infant serum retinol in our statistical models.
Although girls had 1.4-fold higher NAb concentrations (P < 0.001), sex did not modify the vitamin
A effect.
Conclusions: In an undernourished population, maternal vitamin A supplementation enhanced NAb
concentrations of preadolescent children. We posit that this was due to a greater allotment of B1a
precursors during fetal life and a sustained higher count of NAb-secreting B1a cells.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
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Vitamin A deﬁciency is widely prevalent in developing
countries. A combination of inadequate diet, increased nutrient
demand in pregnancy, and high parity place reproductive-aged
women at particular risk. Globally, an estimated 19.1 million
pregnant women have low serum retinol concentrations (<0.70
mmol/L) and, of these, roughly 10 million are affected by mod-
erate to severe deﬁciency resulting in gestational night blindness
[1]. Although the role of vitamin A in immune function is well
accepted [2], little is known about the effect of early exposure to
vitamin A deﬁciency on the emerging immune system. Data from
Malawi indicate that infants born to mothers with low serum
retinol had a threefold higher likelihood of mortality than thosecle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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tional night blindness was associated with a 63% higher risk for
death in the ﬁrst 6 mo of life [4]. This risk was substantially
reduced by weekly supplementation of mothers with low-dose
vitamin A or b-carotene. Although the survival beneﬁt of sup-
plementation was limited to infants of night-blind mothers in
this trial [5], it is possible that detecting alterations to the
developing immune system in less severe cases of deﬁciency
would require more sensitive functional indicators.
Lymphopoiesis may be particularly vulnerable to early insult
[6]. Immune cells of the lymphoid lineage arise from distinctive
waves of progenitor cells in the bone marrow. The most basic
lymphocytesdthe innate-like B1a cells and certain gd T cellsd
are the products of an early wave of progenitors, unique to the
fetal and neonatal period [7]. This endowment of long-lived early
progenitor cells sustains innate-like lymphocyte populations at
tightly regulated levels throughout life [8]. In B lymphopoiesis,
the earliest developmental wave endows individuals with a
long-lived, self-sustaining population of B1a lymphocyte pre-
cursors [7]. Unlike conventional B2 lymphocytes, B1a cells do not
enter germinal centers or undergo afﬁnity maturation. Rather,
they constitutively produce most of the body’s innate-like, low-
afﬁnity natural immunoglobulin (Ig)M with broad speciﬁcity for
certain evolutionarily important epitopes [8]. Subsequent lym-
phopoietic waves give rise to the B1b and B2 cell populations,
with an increasing capacity to recognize and reﬁne antibody
responses to speciﬁc antigens.
Vitamin A, and speciﬁcally its active derivative, retinoic acid
(RA), is critical for early lymphopoiesis [9]. Deﬁciency in fetal
mice has been shown to compromise the B1 cell populations
[10]. We hypothesized that, in a vitamin A-deﬁcient population,
exposure to supplemental vitamin A in utero and via breast milk
would permanently increase the allotment of long-lived B1a
precursors. These precursors would sustain a larger B1a cell
population and higher circulating NAb concentrations.
Materials and methods
Participants for this study were children, ages 9 to 13 y, born to women
enrolled in the NNIPS (Nepal Nutrition Intervention Project-Sarlahi)-2 maternal
supplementation trial conducted in the Sarlahi district of Nepal from 1994
to 1997.
The NNIPS-2 trial was a community-based, cluster-randomized, controlled
trial designed to assess the effect of weekly supplementationwith vitamin A or b-
carotene from preconception through postpartum on maternal, fetal, and infant
health and survival. Methods and results of the NNIPS-2 trial have been previ-
ously published [11]. Brieﬂy, all married women living in the study area (270
wards) were considered eligible and verbal consent was obtained for their
participation. Womenwere randomized byward to receive one of three identical,
coded supplementsdvitamin A (7000 mg as retinyl palmitate), b-carotene (42mg
of all trans–b-carotene; 7000 mg retinol equivalents, assuming a 6-to-1 conver-
sion ratio), or a placeboddesigned to ensure they met their recommended di-
etary allowance (RDA) of vitamin A. Capsules were delivered on aweekly basis by
a cadre of local women distributors, at which time informationwas also collected
on pregnancy and vital status, menses in the past week, and treatment compli-
ance. As distributors reported pregnancies back to the ﬁeld ofﬁce, trained ﬁeld-
workers were dispatched to the household to collect detailed information on
mothers and their infants.
Data available from four home visits (early and late pregnancy; 3- and 6-mo
postpartum) encompass household demographic characteristics, socioeconomic
status (SES), anthropometry, maternal and infant dietary andmorbidity histories,
and other exposures (e.g., maternal substance use, tetanus vaccination, and
strenuous work). Women in a subset of 27 contiguous wards consented to
additional health and nutritional status assessments at the study clinic (mid-
pregnancy and 3 mo postpartum) and at home within 2 wk after the child’s birth
(13  11 d). Venous blood was collected fromwomen at both clinic visits. A heel
prick blood sample was taken from infants at the postpartum clinic visit. Pro-
cessed samples were shipped in liquid nitrogen to the Center for Human Nutri-
tion Laboratory in Baltimore and stored at 70C until analyzed. Retinol and
b-carotene concentrations were measured in serum and breast milk samplesusing reversed-phase high performance liquid chromatography, as previously
described [12].
Children born to mothers enrolled in the NNIPS-2 trial were contacted again
between 2006 and 2008 as part of a house-to-house follow-up study to evaluate
longer-term developmental and functional outcomes. Fieldworkers collected
information from mothers or primary caretakers on children’s vital status, the
presence or absence of 10 commonmorbidity symptoms over the previous week,
usual and past week dietary intake, and SES. Fieldworkers also collected a 10-mL
venous blood sample into sodium heparin-containing collection tubes. Samples
were immediately returned to the project ﬁeld laboratory and centrifuged at
1530g for 10 min at room temperature. Plasma was separated into four 1.5 mL
aliquots, stored in liquid nitrogen, and shipped to the Johns Hopkins Bloomberg
School of Public Health in Baltimore, Maryland on a semimonthly schedule for
storage at 70C. The present work was carried out in the plasma archive of
children (N ¼ 290) meeting our eligibility criteria:
1. First pregnancy tracked during the supplementation trial, although women
may have had more than one pregnancy over the course of the trial,
2. Singleton birth, and
3. All biospecimens being available from bothmothers during the original trial
and children from the follow-up study.
The procedures of the original trial were reviewed and approved by the Joint
Committee on Clinical Investigation at the Johns Hopkins School of Medicine, the
Nepal Health Research Council in Kathmandu, and the Teratology Society in
Bethesda, Maryland. The follow-up study protocol received ethical approval from
the Institutional Review Board at Johns Hopkins and the Institute of Medicine at
Tribhuvan University in Kathmandu, Nepal.
Laboratory analyses
Our hypothesis on B1a lymphopoiesis was developed after data collection
had already been completed in the ﬁeld. Thus, our analyses were limited to work
with extant plasma samples. We proposed that, in this undernourished setting,
maternal supplementation would yield a greater allotment of B1a precursors,
sustaining a higher B1a cell count throughout life. As NAb are the unique and
constitutively secreted protein products of B1a cells [8] and measureable in
cryopreserved plasma, we used these as a proxy. There are numerous potential
NAb speciﬁcities. We selected one speciﬁcitydIgM targeting double-stranded
DNA (dsDNA)dthat has been well-characterized as part of the germline-
encoded, low-afﬁnity NAb repertoire [13], which is detectable at regulated con-
centrations in normal human subjects throughout the life course [14,15].We used
a commercial sandwich ELISA to measure anti-dsDNA IgM in plasma samples
from children at the time of follow-up (ALPCO Diagnostics, Salem, NH, USA;
Catalog # 35-DSSHU-E01), using recombinant human dsDNA as a capture antigen
and horseradish-peroxidase-conjugated antihuman IgM for detection. Human
serum of known anti-dsDNA IgM concentrations (range 0–300 U/mL; functional
sensitivity 1.0 U/mL) was used for calibration. We estimated intraassay precision
using 10 replicates of one quality control sample. Interassay precision was
calculated from quality control samples included on each plate. We ran all
standards, controls, and samples in duplicate. Samples were rerun if the coefﬁ-
cient of variation (CV) of the pair exceeded 20%. The intraassay CV averaged 6.2%
and the interplate CV was 14.3% (n ¼ 9). As no international reference calibration
is available for anti-dsDNA IgM, our ﬁndings were calibrated and data are pre-
sented using arbitrary units (U/mL).
We measured plasma concentrations of C-reactive protein (CRP) and
a1-acid glycoprotein (AGP) as markers of current infection (CRP 5 mg/L or
AGP 1 mg/mL [16]). For CRP, we purchased a high-sensitivity chemilumi-
nescent immunoassay (Siemens Medical Solutions Diagnostics, Tarrytown, NY,
USA; Catalog # LKCRP1) for the Immulite analyzer (Siemens Medical Solutions
Diagnostics; Immulite 1000). This assay employs a solid-phase, anti–ligand-
coated bead and a liquid phase consisting of a ligand-labeled monoclonal
antihuman CRP antibody and alkaline phosphatase-conjugated polyclonal
antihuman CRP. AGP was quantitated using a radial immunodiffusion assay
procured from Kent Laboratories (Bellingham, WA, USA; Catalog #123511).
Interassay precision was 12% and 3% for CRP and AGP, respectively. All labo-
ratory analyses were carried out in the Center for Human Nutrition Laboratory
at the Johns Hopkins Bloomberg School of Public Health in Baltimore,
Maryland.
Statistical analyses
Our a priori hypothesis for this analysis was that children whose mothers
received their weekly RDA of vitamin A or b-carotene would have higher plasma
concentrations of anti-dsDNA IgM. We ﬁrst tested for differences between sup-
plement allocation groups in terms of maternal and household characteristics at
baseline, treatment compliance, and characteristics of children at the time of
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egorical variables, respectively. All analyses were carried out on an intent-to-
treat basis. Between-group differences signiﬁcant at P < 0.2 were ﬂagged. We
then used simple linear regression to assess relationships between those ﬂagged
variables and our continuous outcome. Variables that differed by supplement
allocation and were also associated at P < 0.2 with NAb concentrations were
considered in multivariate models.
We used multiple linear regression modeling to test the impact of mater-
nal supplement allocation on NAb concentrations. Generalized estimating
equations were used to derive standard errors to account for the NNIPS-2
cluster-randomized design [17]. Based on our univariate analyses, we included
all variables that were associated with both maternal allocation group and NAb
concentration (P < 0.2) as potential confounders in the multivariate models.
Exceptions included maternal morbidity and both maternal and infant serum
retinol concentrations, which were all strongly inﬂuenced by supplementation
[11,12] and considered as potential mediating factors. A ﬁnal, parsimonious
model was generated using backward stepwise regression, retaining maternal
supplement allocation and all variables signiﬁcant at P < 0.1 in the full model.
Concerns have been raised that early life exposure to supplemental vitamin A
may interact with childhood vaccination, and may have a differential impact on
girls and boys [18]. A hypothesis has also been put forward that early life vitamin
A supplementation may interact with immunization, acting as an adjuvant to
amplify the nonspeciﬁc effects of vaccines [19]. We tested for effect modiﬁcation
by entering an interaction terms into the full model for child’s sex. Although data
were unavailable on exposure to childhood vaccinations, we did have informa-
tion on whether mothers had received the tetanus toxoid vaccination during
their pregnancy with the child subject. We used this information as a proxy to
test for effect modiﬁcation by vaccination in our models, assuming: 1) children
whose mothers were vaccinated during pregnancy were likely to have been
reached with childhood vaccinations and 2) maternal tetanus toxoid vaccination
may itself be associated with nonspeciﬁc immune activation, to which the fetus
was potentially exposed.
Model ﬁt was tested by reviewing residuals for normality and extreme out-
liers, and by plotting residuals against predicted values to look for any deviations
from a random scatter. Residuals were also plotted against all dependent vari-
ables, including those that had been removed from our parsimonious model.
Finally, our previous analyses showed strong associations between supplemen-
tation and both maternal and infant serum retinol concentrations. As supple-
mentation was expected to act by raising serum retinol concentrations, we
employed serum retinol measures in sensitivity analyses. For these, we restricted
our sample to mothers and infants in the placebo arm of the trial. We then
generated models for each of the outcome variables using either maternal serum
retinol concentrations during pregnancy or infant serum retinol at 3 mo post-
partum as alternate primary exposure variables (i.e., in the place of maternal
supplement allocation).
We used Stata Statistical Software: Release 10 (Stata Corporation, College
Station, TX, USA 2007) for all statistical analyses. P < 0.05 was considered sta-
tistically signiﬁcant.Results
We identiﬁed 445 singleton, live-born children for whom
complete clinical data were available from mid-pregnancy
and early infancy (Fig. 1). Of these, 438 survived and were
resident in the study area at the time of the 2006 NNIPS Cohort
Follow-up census. We completed household interviews with
95% of the resident children (n ¼ 418); however, 68 children
were not met for biospecimen collection. An additional 20
children were excluded due to insufﬁcient plasma. Our ﬁnal
sample size was 290 children, representing 66% of the surviving
and resident children born to mothers enrolled in the NNIPS-2
trial. Follow-up rates did not differ by supplement allocation. As
compared with the larger NNIPS-2 clinical subsample (with
incomplete biospecimen archives) and the full NNIPS-2 sample,
those in our study differed by caste (77% low caste or non-Hindu
versus 87% and 86%, P< 0.001), radio ownership (37% compared
with 32% and 28%, P < 0.001), and farmland ownership (35%
owned >1 hectare compared with 21% and 20%, P < 0.001).
Maternal and household characteristics of our sample at the
time of the original trial are summarized in Table 1. Although
supplement allocation groups were comparable with respect to
age, arm circumference, and other factors in the full trial sample[11], we found imbalances in baseline characteristics in the
subsample eligible for this analysis. Differences suggested that
households in the b-carotene arm may have been of somewhat
higher SES. At the time of follow-up (Table 2), characteristics of
the children born to trial participants were largely comparable
across the three maternal supplement groups. All imbalances
between groups were considered in our multivariate modeling.
Anti-dsDNA IgM concentrations were positively skewed and
required natural log transformation to approximate a normal
distribution. As such, we report all ﬁndings as geometric means.
Geometric means of natural IgM concentrations at follow-up
were 20.08 U/mL (95% conﬁdence interval [CI], 17.82–22.64) in
children born to vitamin A-supplemented mothers compared
with 17.64 U/mL (95% CI, 15.70–9.81) and 15.96 U/mL (95% CI,
13.43–18.96) in those born into the b-carotene and placebo
groups (P ¼ 0.07; analysis of variance), respectively. After
adjusting for minor differences between supplement groups at
the time of follow-up, maternal vitamin A supplementation
increased children’s NAb concentrations by 0.34 SD (Fig. 2)
compared with the placebo group (P ¼ 0.02). Maternal b-caro-
tene supplementation had no effect. Adding a variable for infant
serum retinol to our model reduced the b-coefﬁcient for vitamin
A by roughly 20%, suggesting that the effect of maternal vitamin
A supplementation was mediated, in part, by improving infant
vitamin A status.
Although concentrations of anti-dsDNA IgM among girls were
1.4-fold higher than among boys (P < 0.001), there was no evi-
dence that maternal supplement allocation had a differential
effect by child’s sex (P¼ 0.99). NAb concentrations also tended to
be higher among children born to mothers who had received the
tetanus toxoid vaccine during pregnancy (P ¼ 0.1); however, our
data did not support any effect modiﬁcation by maternal vacci-
nation status.
To test our ﬁndings, we ﬁrst considered the potential inﬂu-
ence of current infection. We found no correlation between
natural IgM concentrations and either of the measured acute-
phase proteins (r ¼ 0.03, P ¼ 0.46 for CRP; r ¼ 0.02, P ¼
0.73 for AGP). Adding variables for CRP and/or AGP to our sta-
tistical models did not change the coefﬁcients for b-carotene or
vitamin A, and excluding children with elevated acute-phase
proteins (CRP 5 mg/L; AGP 1 mg/dL; n ¼ 80) strengthened
the effect of vitamin A supplementation (b ¼ 0.31, P ¼ 0.03). We
further assessed the relationship between children’s NAb con-
centrations and the vitamin A status of their mother during
pregnancy. This sensitivity analysis was restricted to the placebo
group (n ¼ 70), limiting our power. However, we did observe a
nonsigniﬁcant direct relationship between natural IgM concen-
trations in preadolescent children and maternal serum retinol at
mid-gestation (Fig. 3). Of note, supplementation with preformed
vitamin A had a greater effect on maternal status than did b-
carotene (0.18  0.06 mmol/L versus 0.05  0.05 mmol/L increase
over placebo for vitamin A or b-carotene, respectively; simple
linear regression), perhaps explaining the lack of increase in
natural IgM among children born in the b-carotene group.
Discussion
Vitamin A is essential for fetal hematopoiesis, including the
development of the B1a cell lineage during fetal and neonatal life
[9,20]. B1a cells are the predominant source of NAbs [21–23],
such as the anti-dsDNA IgMmeasured in this study. In a deﬁcient
population, we found that children whose mothers had received
their weekly RDA of vitamin A throughout pregnancy and
lactation had higher NAb concentrations in late childhood than
27 wards, ≈ 2,300 women
Random Assignment
(1994-1997)
Placebo (9 wards) Vitamin A (9 wards)Beta-Carotene (9 wards)
Enrolled @ 1st reported 
pregnancy during trial
n = 713
Moved/lost: 53
Live birth pre-visit: 101
Miscarriage/stillbirth: 18
Maternal death: 3
Refusal: 183
No biospecimen: 31
Provided biospecimen at 
antenatal clinic visit 
n = 324
Not pregnant: 23
Miscarriage/stillbirth: 16
Maternal death: 1
Multiples birth: 9
Live, singleton births
n = 275
Not met/refused: 78
No biospecimen: 81
Provided biospecimen at 
post partum clinic visit
n = 116
Moved or died: 3
Not met: 3
Completed follow-up 
interview (2006-2008)
n = 110
Provided biospecimen at 
follow-up
n = 71
No blood draw: 30
Insufficient plasma: 9
Moved or died: 2
Not met: 7
Enrolled @ 1st reported 
pregnancy during trial
n = 793
Moved/lost: 29
Live birth pre-visit: 125
Miscarriage/stillbirth: 28
Maternal death: 0
Refusal: 148
No biospecimen: 21
Provided biospecimen at 
antenatal clinic visit 
n = 442
Not pregnant: 32
Miscarriage/stillbirth: 19
Maternal death: 1
Multiples birth: 16
Live, singleton births
n = 374
Not met/refused: 94
No biospecimen: 93
Provided biospecimen at 
post partum clinic visit
n = 187
Completed follow-up 
interview (2006-2008)
n = 178
Provided biospecimen at 
follow-up
n = 123
No blood draw: 49
Insufficient plasma: 6
Moved or died: 2
Not met: 10
Enrolled @ 1st reported 
pregnancy during trial
n = 757
Moved/lost: 63
Live birth pre-visit: 97
Miscarriage/stillbirth: 22
Maternal death: 0
Refusal: 181
No biospecimen: 31
Provided biospecimen at 
antenatal clinic visit 
n = 363
Not pregnant: 23
Miscarriage/stillbirth: 18
Maternal death: 0
Multiples birth: 13
Live, singleton births
n = 309
Not met/refused: 70
No biospecimen: 97
Provided biospecimen at 
post partum clinic visit
n = 142
Completed follow-up 
interview (2006-2008)
n = 130
Provided biospecimen at 
follow-up
n = 96
No blood draw: 29
Insufficient plasma: 5
Fig. 1. Enrollment, participation, and losses to follow-up of children ages 9 to 13 y in rural Nepal by maternal supplement allocation. If participants had more than one
pregnancy during the trial, only the ﬁrst pregnancy was considered for the present analysis. Only children with a complete biospecimen archive were eligible for the present
study. Biospecimens may have been unavailable due to refusals or insufﬁcient sample volumes for analysis.
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serum retinol concentrations. As such, it is possible that the null
effect of maternal b-carotene supplementation was due to this
supplement’s lesser effect on infant serum retinol.
Higher NAb concentrations in these children may be the
result of more efﬁcient antibody production by B1a cells, which
is known to be inﬂuenced by retinol status [24,25]. Alternatively,
it may reﬂect a higher B1a cell count. The former explanation
seems unlikely, as this would require a sustained higher intake of
vitamin A among children born to supplemented mothers.
Normalizing the vitamin A status of reproductive-aged women
more likely protected the earliest wave of lymphopoiesis. Thus,our data are most consistent with a hypothesis that early life
exposure to supplemental vitamin A ensured a larger or more
robust population of early progenitor cells, sustaining a higher
count of natural IgM-secreting B1a cells.
Our ﬁndings are supported by animal studies showing the
critical importance of RA in hematopoiesis [26]. Although much
of this work has focused on the myeloid lineage, some recent
studies suggest a role for RA in regulating B lymphopoiesis.
Treatment of cultured adult B lymphoid progenitors from
healthy mice with all-trans-RA shortened the time required for
their differentiation into CD19-positive cells [27], likely due to
the role of RA in expression of transcription factors EBF1 and
Table 1
Characteristics of mothers and households at time of index pregnancy* in the NNIPS-2 maternal supplementation trial, by supplement allocation, Sarlahi, Nepal
(1994–1997)
Placebo n ¼ 70 n (%) b-carotene n ¼ 121 n (%) Vitamin A n ¼ 96 n (%)
Maternal characteristics
Age (y; n ¼ 1 missing)
<20 15 (21.4) 27 (22.0) 16 (16.7)
20–30 46 (65.7) 70 (56.9) 68 (70.8)
>30 9 (12.9) 26 (21.1) 12 (12.5)
Primiparous (n ¼ 3 missing) 16 (22.5) 29 (23.8) 23 (24.5)
Arm circumference <21.5 cm (n ¼ 7 missing) 42 (60.0) 58 (47.9) 55 (59.8)
Behavioral characteristics
Strenuous work 2 d/wk 29 (40.8) 49 (39.8) 40 (41.7)
Smoked cigarettes (n ¼ 5 missing; P < 0.05y) 5 (7.1) 25 (20.5) 20 (21.5)
Drank alcohol (n ¼ 5 missing) 0 (0.0) 6 (4.9) 2 (2.2)
Compliance with supplementation 80% (P < 0.01) 53 (74.6) 70 (56.9) 71 (74.0)
Socioeconomic indicators
Low caste or non-Hindu (n ¼ 5 missing; P < 0.001) 63 (90.0) 78 (63.9) 78 (83.9)
Literate head of household (n ¼ 5 missing; P < 0.001) 33 (47.1) 78 (63.9) 36 (38.7)
Asset ownership
Radios (n ¼ 5 missing; P < 0.05) 26 (37.1) 54 (44.3) 24 (25.8)
Goats (n ¼ 5 missing) 47 (67.1) 70 (57.4) 51 (54.8)
Cattle (n ¼ 5 missing) 55 (78.6) 87 (71.3) 62 (66.7)
Khet farmland, 1 hectares (n ¼ 6 missing; P < 0.001) 35 (50.0) 47 (38.5) 18 (19.6)
* Participants may have had >1 pregnancy during the NNIPS-2 trial; only ﬁrst reported pregnancies (index) were considered for the present study.
y All P-values based on c2 test.
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in a similar manner, the researchers did note a stark reduction in
both B1a and B1b cells in mice exposed in utero and during the
neonatal period to vitamin A deﬁciency [10]. This reduction
could be corrected by RA [10]. We are not aware of any compa-
rable research on the T lineage.
An impact of early vitamin A deﬁciency on lymphopoiesis
may have relevance for the current debate regarding mecha-
nisms of action for neonatal vitamin A supplementation [28–30].
Newborn dosing with vitamin A may act on the earliest
lymphoid progenitors, boosting their differentiation into B1a or
gd T cells. These innate-like lymphocytes would provide crucial
protection for neonates without prior exposure to common
pathogens [8]. An impact primarily on the earliest wave ofTable 2
Characteristics of children, ages 9 to 13 y, born to NNIPS-2 maternal sup-
plementation trial participants, by supplement allocation, Sarlahi, Nepal
(2006–2008)
Placebo
n ¼ 70 n (%)
b-carotene
n ¼ 121 n (%)
Vitamin A
n ¼ 96 n (%)
Child characteristics
Sex
Male 38 (53.5) 67 (54.5) 46 (47.9)
Female 33 (46.5) 56 (45.5) 50 (52.1)
Age at follow-up (y)
<11 14 (19.7) 36 (29.3) 28 (29.2)
11–12 42 (59.2) 65 (52.8) 50 (52.1)
>12 15 (107.1) 22 (61.1) 18 (64.3)
Height-for-age
2 Z-scores 31 (43.7) 52 (42.3) 46 (47.9)
<2 Z-scores 40 (56.3) 71 (57.7) 50 (52.1)
Morbidity symptoms in week
before blood draw
Poor appetite, vomiting,
or both
8 (11.3) 17 (13.8) 6 (6.3)
Diarrhea/dysentery 1 (1.4) 6 (4.9) 3 (3.1)
Fever 2 (2.8) 11 (8.9) 10 (10.4)
Productive cough, rapid
breathing, or both
2 (2.8) 14 (11.4) 9 (9.4)
Painful urination 2 (2.8) 5 (4.1) 2 (2.1)
Ear discharge (P < 0.05)* 1 (1.4) 1 (0.8) 7 (7.3)
* Based on c2 test.progenitors, versus themore transitional or adult-like progenitor
cells arising during infancy, may further explain why the timing
of dosing appears to modify the protective effect of neonatal
supplementation [30]. Concerns regarding neonatal dosing have
centered on their potential interactions with childhood vacci-
nations, particularly among girls [18,31]. We found no evidence
that the effect of maternal vitamin A supplementation on NAb
concentrations differed by child’s sex, maternal tetanus toxoid
vaccination (as a proxy for likely having received childhood
vaccination), or both. However, girls and childrenwhosemothers
were vaccinated against tetanus toxoid did have higher NAb
concentrations overall.
A reduction in the B1a lymphocyte population and circulating
natural antibodies has broad relevance. Natural IgM protect
against encapsulated bacteria such as Streptococcus pneumonia
[32], a major cause of morbidity and mortality in the developing
world. These innate-like defensive proteins are produced irre-
spective of age or prior pathogen exposure and are therefore
particularly important in early infancy [23]. Emerging research is
also highlighting the role of natural antibodies in responding to
malignant cells [33] and in “housekeeping” after oxidative stress-
induced damage or conventional apoptosis [34]. Reductions in
B1a cells and natural IgM can therefore have implications for
immune-mediated or inﬂammatory diseases in later life. This is
evidenced by epidemiologic studies linking low concentrations
of certain NAb speciﬁcities with an increased risk for cardio-
vascular disease [35] and stroke [36].
The major strength of this study was the nature of the expo-
sure, inwhich womenwere randomized by cluster to one of three
trial arms. The NNIPS-2 trial was also unique in that supplements
were delivered from before conception through lactation, pre-
sumably assuring exposure to vitamin A or b-carotene throughout
the full critical period of early lymphopoiesis. We had access to an
extensive database of information regardingmaternal/fetal health
and nutrition from early pregnancy through the time of birth, as
well as information about mothers and their infants throughout
the postpartum period. Additionally, we were able to recontact,
interview, and collect biospecimens from almost 70% of children
born during this trial more than 10 y later. However, our study
does have limitations. Given our requirements for biospecimens
10
15
20
25
30
A
nt
i-d
sD
N
A
 Ig
M
 (U
/m
L)
Placebo β-carotene Vitamin A
*
Fig. 2. Effect of maternal vitamin A or b-carotene supplements delivered weekly
from preconception through postpartum on natural antibody concentrations of
children ages 9 to 13 y in rural Nepal (n ¼ 250). Values are geometric means (95%
conﬁdence intervals), adjusted for the design effect, maternal vaccination during
pregnancy, current child ear discharge status, and household assets (mobile phone,
farmland). *Signiﬁcantly different from placebo, P < 0.05. IG, immunoglobulin.
A. C. Palmer et al. / Nutrition 31 (2015) 813–819818from mothers and their infants or children during pregnancy,
postpartum, and later in life, our sample was not fully represen-
tative of the original trial. This highly compliant subsample tended
to be of better SES. We also found minor differences between
supplementation allocation groups in our subsample that were
not apparent in the larger trial [11]. Although we attempted to
control for these factors in our models, there is the possibility of
some residual confounding.
The primary limitation of our study was in characterizing
early lymphopoiesis. As this hypothesis was not posed until after
our ﬁeld data collection was completed, we were limited to
measuring markers in cryopreserved plasma samples. NAb
concentrations have not been previously validated as a marker of
the B1a population. However, NAb are constitutively produced
by B1a cells and are thought to be protein products unique to
these cells [37]. We measured only one NAb speciﬁcity: anti-
dsDNA IgM. Unlike anti-dsDNA IgG, the IgM isotype is protec-
tive against lupus-associated pathology [38], in support of it2.
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Fig. 3. Relationship between natural antibody concentrations of children ages 9 to
13 y in rural Nepal and maternal serum retinol concentrations at mid-pregnancy
(placebo group only; n ¼ 70), adjusted for maternal fruit and vegetable intake
during pregnancy. Fit (line) and conﬁdence intervals (shaded area) of multiple
linear regressions with generalized estimating equations. Ig, immunoglobulin.being a natural rather than pathogenic antibody. It is possible
that anti-dsDNA IgM may not be representative of total NAb
concentrations. Future studies should directly measure counts of
innate-like B cells. This work should also be extended to the T
lineage, where human studies reveal a strong regulatory bias of
fetal stem cell–derived T lymphocytes [39].
Given the self-sustaining nature of fetal progenitors and their
sensitivity to vitamin A nutriture, early life exposure to vitamin A
deﬁciency could have a lasting impact on their progenydthe
innate-like lymphocyte populationsdand the protection that
they afford. Although our work focuses on vitamin A, this can be
viewed as a sentinel nutrient. Gestational deﬁciencies or ex-
cesses in other essential nutrients may also inﬂuence the rapidly
developing immune system, meriting further research on
nutritional modulation of early lymphopoiesis.Conclusion
In an area of endemic vitamin A deﬁciency, we showed that
exposure to supplemental vitamin A in utero and during lacta-
tion increased children’s NAb concentrations. We posit that this
results from a greater allotment of B1a precursors during fetal
life and a sustained higher count of NAb-secreting B1a cells.Acknowledgments
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